Can paroxetine (Paxil) cause nausea, vomiting, and diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Paxil Cause Nausea, Vomiting, and Diarrhea?

Yes, paroxetine (Paxil) commonly causes nausea, vomiting, and diarrhea—these are among the most frequently reported gastrointestinal side effects and are the leading reasons patients discontinue the medication. 1

Frequency and Clinical Significance

Nausea is the most prominent gastrointestinal side effect of paroxetine:

  • Nausea occurs in a substantial proportion of patients and is the most common reason for treatment discontinuation across all indications including major depressive disorder, OCD, panic disorder, social anxiety disorder, generalized anxiety disorder, and PTSD 1
  • In clinical trials, 3.2% of patients with major depressive disorder discontinued paroxetine specifically due to nausea (compared to 1.1% on placebo), and 4.0% of patients with social anxiety disorder discontinued due to nausea (compared to 0.3% on placebo) 1
  • The American College of Physicians identifies nausea and vomiting as the most common reasons for discontinuation in efficacy studies of second-generation antidepressants, including paroxetine 2

Vomiting and diarrhea also occur but are less frequent:

  • Vomiting led to discontinuation in 1.0% of patients with major depressive disorder (compared to 0.3% on placebo) 1
  • Diarrhea caused discontinuation in 1.0% of patients with major depressive disorder (compared to 0.3% on placebo) 1
  • In PTSD trials, diarrhea was among the most commonly observed adverse events (≥5% incidence and at least twice that of placebo) 1

Mechanism and Clinical Context

These gastrointestinal effects result from paroxetine's selective serotonin reuptake inhibition:

  • Paroxetine is a potent and selective inhibitor of serotonin reuptake, 2 to 23 times more potent than other SSRIs, which explains the prominence of serotonergic side effects 3
  • Gastrointestinal side effects are the most common adverse effects of SSRIs as a class and represent the primary cause of treatment discontinuation 4
  • The American Academy of Family Physicians notes that gastrointestinal symptoms should be monitored especially during the first 1-2 weeks of treatment when they are most likely to occur 4

Management Strategies

These side effects are typically mild, transient, and manageable:

  • Nausea and other gastrointestinal effects tend to be relatively mild, transient, and easily managed, rarely leading to dose reduction or drug discontinuation in most patients 5
  • Taking medication with food may help reduce gastrointestinal side effects, especially nausea 4
  • The American Academy of Family Physicians recommends starting with low doses (similar principles apply across SSRIs) to reduce the incidence of gastrointestinal side effects 4

Critical Warning: Serotonin Syndrome

If gastrointestinal symptoms appear as part of a broader constellation, serotonin syndrome must be ruled out:

  • Serotonin syndrome can include nausea, vomiting, and diarrhea along with mental status changes (agitation, confusion), autonomic instability (tachycardia, labile blood pressure, hyperthermia), and neuromuscular symptoms (tremor, rigidity, myoclonus, hyperreflexia) 4
  • This is particularly important in patients on multiple serotonergic medications or with recent dose increases, as serotonin syndrome can arise within 24-48 hours 4
  • Paroxetine should never be coadministered with monoamine oxidase inhibitors due to the risk of lethal interaction 6, 5

Discontinuation Considerations

Abrupt cessation can also cause gastrointestinal symptoms:

  • Paroxetine is associated with discontinuation syndrome, which can include diarrhea, nausea, vomiting, along with dizziness, fatigue, headaches, insomnia, anxiety, and irritability 4
  • A brief taper rather than abrupt cessation is recommended to minimize withdrawal symptoms 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Paroxetine: pharmacokinetics and pharmacodynamics].

Fortschritte der Neurologie-Psychiatrie, 1994

Guideline

Gastrointestinal Effects of Antidepressants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The safety profile of paroxetine.

The Journal of clinical psychiatry, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.